Yıl: 2020 Cilt: 37 Sayı: 1 Sayfa Aralığı: 1 - 3 Metin Dili: İngilizce İndeks Tarihi: 18-06-2021

COVID‑19 Associate Neurological Complications

Öz:
2019‑novel Coronavirus disease (COVID‑19) is a global health problem thataffected >2.000.000 people in the world. Although the main component ofthe disease is pulmonary disturbances, recent reports suggested neurologicalmanifestations. Neurological complications have been rarely reported with otherCoronavirus associated diseases. In this short review, we would like to drawattention to COVID‑19‑related neurological symptoms. Heath‑care providersshould be aware that COVID‑19 can associate neurological manifestations.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967.
  • 2. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814‑20.
  • 3. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, Thrusting Coronaviruses into the spotlight. Viruses 2019;11:59.
  • 4. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565‐74.
  • 5. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631‑7.
  • 6. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497‑506.
  • 7. Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan 2005;14:113‑9.
  • 8. Hwang CS. Olfactory neuropathy in severe acute respiratory
  • 9. Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017;13:227‑33.
  • 10. Turgay C, Emine T, Ozlem K, Muhammet SP, Haydar AT. A rare cause of acute flaccid paralysis: Human coronaviruses. J Pediatr Neurosci 2015;10:280‑1.
  • 11. Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID‑19 in Wuhan, China: A retrospective case series study. MedRxiv; 2020.
  • 12. Jin M, Tong Q. Rhabdomyolysis as potential late complication associated with COVID‑19. Emerg Infect Dis 2020;26. doi: 10.3201/eid2607.200445.
  • 13. Filatov A, Sharma P, Hindi F, Espinoa PS. Neurological complications of coronavirus disease (COVID‑19): Encephalopathy. Cureus 2020;12:e7352.
  • 14. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID‑19‑associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020:201187. doi: 10.1148/radiol.2020201187.
  • 15. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain‑Barré syndrome associated with SARS‑CoV‑2 infection: Causality or coincidence? Lancet Neurol 2020. doi: 10.1016/S1474- 4422(20)30109-5.
  • 16. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82:7264‑75.
  • 17. Li K, Wohlford‑Lenane C, Perlman S, Zhao J, Jewell AK, Reznikov LR, et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis 2016;213:712‐22.
  • 18. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS‑CoV2 may play a role in the respiratory failure of COVID‑19 patients. J Med Virol 2020. doi: 10.1002/jmv.25728.
  • 19. Li YC, Bai WZ, Hirano N, Hayashida T, Taniguchi T, Sugita Y, et al. Neurotropic virus tracing suggests a membranous‐coatingmediated mechanism for transsynaptic communication. J Comp Neurol 2013;521:203‐12.
  • 20. Lai SL, Hsu MT, Chen SS. The impact of SARS on epilepsy: The experience of drug withdrawal in epileptic patients. Seizure 2005;14:557‑61.
APA BAYSAL-KIRAÇ L, UYSAL H (2020). COVID‑19 Associate Neurological Complications. , 1 - 3.
Chicago BAYSAL-KIRAÇ Leyla,UYSAL Hilmi COVID‑19 Associate Neurological Complications. (2020): 1 - 3.
MLA BAYSAL-KIRAÇ Leyla,UYSAL Hilmi COVID‑19 Associate Neurological Complications. , 2020, ss.1 - 3.
AMA BAYSAL-KIRAÇ L,UYSAL H COVID‑19 Associate Neurological Complications. . 2020; 1 - 3.
Vancouver BAYSAL-KIRAÇ L,UYSAL H COVID‑19 Associate Neurological Complications. . 2020; 1 - 3.
IEEE BAYSAL-KIRAÇ L,UYSAL H "COVID‑19 Associate Neurological Complications." , ss.1 - 3, 2020.
ISNAD BAYSAL-KIRAÇ, Leyla - UYSAL, Hilmi. "COVID‑19 Associate Neurological Complications". (2020), 1-3.
APA BAYSAL-KIRAÇ L, UYSAL H (2020). COVID‑19 Associate Neurological Complications. Neurological sciences and neurophysiology (Online), 37(1), 1 - 3.
Chicago BAYSAL-KIRAÇ Leyla,UYSAL Hilmi COVID‑19 Associate Neurological Complications. Neurological sciences and neurophysiology (Online) 37, no.1 (2020): 1 - 3.
MLA BAYSAL-KIRAÇ Leyla,UYSAL Hilmi COVID‑19 Associate Neurological Complications. Neurological sciences and neurophysiology (Online), vol.37, no.1, 2020, ss.1 - 3.
AMA BAYSAL-KIRAÇ L,UYSAL H COVID‑19 Associate Neurological Complications. Neurological sciences and neurophysiology (Online). 2020; 37(1): 1 - 3.
Vancouver BAYSAL-KIRAÇ L,UYSAL H COVID‑19 Associate Neurological Complications. Neurological sciences and neurophysiology (Online). 2020; 37(1): 1 - 3.
IEEE BAYSAL-KIRAÇ L,UYSAL H "COVID‑19 Associate Neurological Complications." Neurological sciences and neurophysiology (Online), 37, ss.1 - 3, 2020.
ISNAD BAYSAL-KIRAÇ, Leyla - UYSAL, Hilmi. "COVID‑19 Associate Neurological Complications". Neurological sciences and neurophysiology (Online) 37/1 (2020), 1-3.